Hims & Hers Health surged to $56.58 per share this afternoon, but it remains 20.5% above its mean target price of $46.95. There may still be room for more downwards movement — even after today's 8.0% drop. Analysts are giving the Large-Cap Medical and Nursing Services stock on average rating of hold, with target prices ranging from $25.0 to $85.0 per share.
Hims & Hers Health has an elevated short interest of 34.6%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 1.19. The company's insiders own 11.09% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. 74.4% of Hims & Hers Health shares are held by institutional investors, which indicates a high level of confidence in the stock.
Institutions Invested in Hims & Hers Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Blackrock Inc. | 11% | 24,244,637 | $1,371,397,858 |
| 2025-03-31 | Vanguard Group Inc | 9% | 18,478,744 | $1,045,250,128 |
| 2025-03-31 | Goldman Sachs Group Inc | 4% | 8,160,169 | $461,579,948 |
| 2025-03-31 | Farallon Capital Management LLC | 4% | 7,953,705 | $449,901,312 |
| 2025-03-31 | State Street Corporation | 3% | 7,443,178 | $421,023,353 |
| 2025-03-31 | Renaissance Technologies, LLC | 3% | 7,024,352 | $397,332,461 |
| 2025-03-31 | Shaw D.E. & Co., Inc. | 3% | 6,030,575 | $341,119,466 |
| 2025-03-31 | Morgan Stanley | 2% | 4,717,398 | $266,839,611 |
| 2025-03-31 | Geode Capital Management, LLC | 2% | 4,674,488 | $264,412,407 |
| 2025-03-31 | Srs Investment Management, Llc | 2% | 4,000,000 | $226,259,994 |
For these reasons, we consider that the Hims & Hers Health is the subject of negative market sentiment.
